05/2009 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 5, 1863 – 2065 2017Podnositelj europske MKP Broj objave europske Naziv izumaprijave patentaprijave patenta(71) (51) (97) (54)Boehringer Ingelheim Pharma GmbH & A61K 9/20 (2006.01)EP 2054041 * FORMULATIONS OF FLIBANSERIN AND METHODCo. KG, DEA61K 9/48 (2006.01)FOR MANUFACTURING THE SAMEBoehringer Ingelheim Pharma GmbH &Co. KG, DEA61K 31/496 (2006.01)A61K 47/10 (2006.01)A61K 47/22 (2006.01)A61K 31/538 (2006.01)A61P 11/00 (2006.01)Boustred, Graham Hubert, NZ B62B 1/10 (2006.01)B62B 1/18 (2006.01)B65F 1/06 (2006.01)B62B 1/14 (2006.01)B65F 1/00 (2006.01)Bristol-Myers Squibb Company, US C07D 403/12 (2006.01)C07D 207/273 (2006.01)A61K 31/4025 (2006.01)Bristol-Myers Squibb Company, US A61K 31/506 (2006.01)A61K 31/501 (2006.01)A61K 31/497 (2006.01)A61K 31/444 (2006.01)A61K 31/4439 (2006.01)A61P 31/12 (2006.01)C07D 401/14 (2006.01)C07D 403/14 (2006.01)Bristol-Myers Squibb Company, US C07D 207/273 (2006.01)A61K 31/4025 (2006.01)C07D 403/12 (2006.01)Bristol-Myers Squibb Company, US C07D 211/18 (2006.01)C07D 211/38 (2006.01)C07D 211/52 (2006.01)C07D 211/58 (2006.01)C07D 211/70 (2006.01)C07D 401/12 (2006.01)C07D 401/14 (2006.01)C07D 405/12 (2006.01)C07D 409/12 (2006.01)C07D 413/12 (2006.01)C07D 417/12 (2006.01)C07D 417/14 (2006.01)C07D 487/04 (2006.01)C07D 491/10 (2006.01)A61K 31/45 (2006.01)Bristol-Myers Squibb Company, US C07D 277/46 (2006.01)EP 2054084 *EP 2043899 *EP 2046779 *EP 2049116 *EP 2049477 *EP 2049486 *EP 2049507 *Bristol-Myers Squibb Company, US C07D 401/12 (2006.01)EP 2049519 *C07D 403/12 (2006.01)C07D 487/04 (2006.01)A61K 31/4025 (2006.01)Bristol-Myers Squibb Company, US C07D 401/14 (2006.01)EP 2049522 *C07D 403/14 (2006.01)A61P 31/12 (2006.01)A61K 31/4025 (2006.01)A61K 31/4178 (2006.01)Bristol-Myers Squibb Company, US C07C 61/39 (2006.01)EP 2054368 *C07C 61/40 (2006.01)C07D 203/18 (2006.01)C07D 205/04 (2006.01)C07D 205/08 (2006.01)C07D 263/04 (2006.01)C07D 263/30 (2006.01)C07D 317/72 (2006.01)C07D 493/08 (2006.01)C07D 295/18 (2006.01)C07C 62/38 (2006.01)C07D 451/02 (2006.01)C07C 57/00 (2006.01)C07C 59/00 (2006.01)Byk-Chemie GmbH, DE C09C 3/12 (2006.01)EP 2049603 *C09C 1/40 (2006.01)Böttcher, Joachim, DE C02F 3/28 (2006.01)EP 2046689 *C02F 1/52 (2006.01)CADILA HEALTHCARE LIMITED, IN C07D 495/04 (2006.01)A61K 31/435 (2006.01)C07D 333/00 (2006.01)C07D 221/00 (2006.01)EP 1927595AEROSOL FORMULATION FOR THE INHALATIONOF BETA AGONISTSPORTABLE CONTAINERMODULATORS OF CHEMOKINE RECEPTORACTIVITY, CRYSTALLINE FORMS AND PROCESSHEPATITIS C VIRUS INHIBITORSMODULATORS OF CHEMOKINE RECEPTORACTIVITY, CRYSTALLINE FORMS AND PROCESSPIPERIDINYL DERIVATIVES AS MODULATORS OFCHEMOKINE RECEPTOR ACTIVITYMODULATORS OF GLUCOCORTICOID RECEPTOR,AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USETHEREOFCYCLIC DERIVATIVES AS MODULATORS OFCHEMOKINE RECEPTOR ACTIVITYHEPATITIS C VIRUS INHIBITORSCYCLIC 11-BETA HYDROXYSTEROIDDEHYDROGENASE TYPE I INHIBITORSSURFACE-MODIFIED PARTICLES ANDPRODUCTION METHODPLANT FOR THE PREPURIFICATION OFCONTAMINATED WATER WITH INTEGRATEDFURTHER TREATMENT OF THE SOLIDSSalts of clopidogrel and process for preparationISSN 1331-2030